Year archive

Sihuan Pharmaceutical Holdings Group Ltd. — 2021 filings

All 126 regulatory filings released by Sihuan Pharmaceutical Holdings Group Ltd. (460) in 2021, sourced directly from the official regulator.

126 Filings

2021 Period

2021 filings (126)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT-ACQUISITION OF THE EQUITY OF AN AMERICAN COMPANY GENESIS BIOSYSTEMS, INC. M&A Activity	2021-12-29	English
CHANGE IN DIRECTOR'S INFORMATION Board/Management Information	2021-12-24	English
Next Day Disclosure Return Transaction in Own Shares	2021-12-23	English
VOLUNTARY ANNOUNCEMENT-FONDAPARINUX SODIUM INJECTION OBTAINED MANUFACTURE APPROVAL Regulatory Filings	2021-12-21	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2021 Regulatory Filings	2021-12-03	English
VOLUNTARY ANNOUNCEMENT-OCTREOTIDE ACETATE INJECTION OBTAINED APPROVAL OF DRUG SUPPLEMENTAL APPLICATION Regulatory Filings	2021-12-01	English
VOLUNTARY ANNOUNCEMENT-XUANZHU BIOPHARM OBTAINED PHASE III CLINICAL TRIAL APPROVAL BIROCICLIB (USED IN COMBINATION WITH AROMATASE INHIBITOR) Regulatory Filings	2021-11-25	English
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE Transaction in Own Shares	2021-11-11	English
Next Day Disclosure Return Transaction in Own Shares	2021-11-11	English
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE Transaction in Own Shares	2021-11-10	English
Next Day Disclosure Return Transaction in Own Shares	2021-11-10	English
VOLUNTARY ANNOUNCEMENT-CLOPIDOGREL BISULFATE TABLETS OBTAINED MANUFACTURE APPROVAL Regulatory Filings	2021-11-09	English
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE Transaction in Own Shares	2021-11-05	English
Next Day Disclosure Return Transaction in Own Shares	2021-11-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2021 Share Issue/Capital Change	2021-11-03	English
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE Transaction in Own Shares	2021-10-26	English
Next Day Disclosure Return Transaction in Own Shares	2021-10-26	English
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE Transaction in Own Shares	2021-10-25	English
Next Day Disclosure Return Transaction in Own Shares	2021-10-25	English
VOLUNTARY ANNOUNCEMENT-XUANZHU BIOPHARM OBTAINED PHASE III CLINICAL TRIAL APPROVAL FOR NEW DRUG XZP-3621 Regulatory Filings	2021-10-25	English
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE Transaction in Own Shares	2021-10-22	English
Next Day Disclosure Return Transaction in Own Shares	2021-10-22	English
VOLUNTARY ANNOUNCEMENT-NEW DRUG APPLICATION OF XUANZHU BIOPHARM'S DRUG ANAPRAZOLE SODIUM ACCEPTED BY NMPA Regulatory Filings	2021-10-22	English
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE Transaction in Own Shares	2021-10-21	English
Next Day Disclosure Return Transaction in Own Shares	2021-10-21	English
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE Transaction in Own Shares	2021-10-18	English
Next Day Disclosure Return Transaction in Own Shares	2021-10-18	English
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE Transaction in Own Shares	2021-10-15	English
Next Day Disclosure Return Transaction in Own Shares	2021-10-15	English
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE Transaction in Own Shares	2021-10-08	English
Next Day Disclosure Return Transaction in Own Shares	2021-10-08	English
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE Transaction in Own Shares	2021-10-07	English
Next Day Disclosure Return Transaction in Own Shares	2021-10-07	English
Next Day Disclosure Return Transaction in Own Shares	2021-10-06	English
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE Transaction in Own Shares	2021-10-06	English
Next Day Disclosure Return Transaction in Own Shares	2021-10-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2021 Regulatory Filings	2021-10-04	English
VOLUNTARY ANNOUNCEMENT-CLARIFICATION REGARDING CERTAIN MEDIA REPORTS Regulatory Filings	2021-09-30	English
VOLUNTARY ANNOUNCEMENT-SIHUAN PHARMACEUTICAL OBTAINED MEDICAL DEVICE MANUFACTURING LICENSE FOR SELF-DEVELOPED PRODUCT PLLA GEL "Karlian" Regulatory Filings	2021-09-30	English
VOLUNTARY ANNOUNCEMENT-STRATEGIC COLLABORATION BETWEEN XUANZHU BIOPHARM OF SIHUAN PHARM AND WUXI XDC ON DEVELOPMENT AND MANUFACTURING OF KM501 BISPECIFIC ANTIBODY DRUG CONJUGATE Regulatory Filings	2021-09-29	English
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE Transaction in Own Shares	2021-09-28	English
Next Day Disclosure Return Transaction in Own Shares	2021-09-28	English
VOLUNTARY ANNOUNCEMENT-METOPROLOL SUCCINATE EXTENDED-RELEASE TABLETS OBTAINED DRUG REGISTRATION CERTIFICATE Regulatory Filings	2021-09-28	English
Next Day Disclosure Return Transaction in Own Shares	2021-09-27	English
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE Transaction in Own Shares	2021-09-27	English
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE Transaction in Own Shares	2021-09-24	English
Next Day Disclosure Return Transaction in Own Shares	2021-09-24	English
VOLUNTARY ANNOUNCEMENT - SIHUAN AND SIGNALCHEM LIFESCIENCES CORPORATION ANNOUNCE COLLABORATION AND LICENSING AGREEMENT FOR SLC-391 IN THE GREATER CHINA REGION Capital/Financing Update	2021-09-24	English
Next Day Disclosure Return Transaction in Own Shares	2021-09-21	English
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE Transaction in Own Shares	2021-09-20	English
Next Day Disclosure Return Transaction in Own Shares	2021-09-20	English
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE Transaction in Own Shares	2021-09-17	English
Next Day Disclosure Return Transaction in Own Shares	2021-09-17	English
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE Transaction in Own Shares	2021-09-16	English
Next Day Disclosure Return Transaction in Own Shares	2021-09-16	English
Notification Letter and Request Form to Non-registered Holder Report Publication Announcement	2021-09-16	English
Notification Letter and Change Request Form to Registered Shareholder Report Publication Announcement	2021-09-16	English
Interim Report 2021 Interim / Quarterly Report H1 2021	2021-09-16	English
VOLUNTARY ANNOUNCEMENT - PRC MARKETING APPROVAL OF LACOSAMIDE TABLETS Regulatory Filings	2021-09-08	English
VOLUNTARY ANNOUNCEMENT - XUANZHU BIOPHARM'S MEDICAL PRODUCT XZP-6019 OBTAINED APPROVAL FOR CLINICAL TRIALS OF NON-ALCOHOLIC FATTY LIVER DISEASE Regulatory Filings	2021-09-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2021 Share Issue/Capital Change	2021-09-03	English
GRANT OF SHARE OPTIONS Share Issue/Capital Change	2021-09-01	English
VOLUNTARY ANNOUNCEMENT - FUDANAFIL OBTAINED CLINICAL TRIAL APPROVAL IN RELATION TO INDICATIONS FOR PULMONARY ARTERIAL HYPERTENSION Regulatory Filings	2021-09-01	English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2021 Interim / Quarterly Report H1 2021	2021-08-31	English
Next Day Disclosure Return Share Issue/Capital Change	2021-08-30	English
VOLUNTARY ANNOUNCEMENT Regulatory Filings	2021-08-27	English
NOTICE OF BOARD MEETING Report Publication Announcement	2021-08-19	English
VOLUNTARY ANNOUNCEMENT - XUANZHU BIOPHARM AND THE U.S. COMPANY HB THERAPEUTICS, INC. COLLABORATE TO DEVELOP NOVEL TARGETED PROTEIN DEGRADATION TECHNOLOGY Regulatory Filings	2021-08-13	English
VOLUNTARY ANNOUNCEMENT-Xuanzhu Biopharm Obtained Phase III Clinical Trial Approval For Class 1 New Drug Birociclib Regulatory Filings	2021-08-12	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Board/Management Information	2021-08-06	English
RESIGNATION OF NON-EXECUTIVE DIRECTOR Board/Management Information	2021-08-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2021 Regulatory Filings	2021-08-04	English
VOLUNTARY ANNOUNCEMENT - INSULIN ASPART 30 INJECTION DEVELOPED BY SIHUAN PHARMACEUTICAL ACHIEVED EQUIVALENT CLINICAL RESULTS IN EFFICACY AND SAFETY STUDY AS ORIGINATOR DRUG Regulatory Filings	2021-07-30	English
POSITIVE PROFIT ALERT Earnings Release H1 2021	2021-07-27	English
Reply Form Regulatory Filings	2021-07-21	English
Election of Language and Means of Receipt of Corporate Communications Regulatory Filings	2021-07-21	English
VOLUNTARY ANNOUNCEMENT Regulatory Filings	2021-07-13	English
VOLUNTARY ANNOUNCEMENT - SIHUAN PHARMACEUTICAL OBTAINED DRUG REGISTRATION CERTIFICATE FOR MOXIFLOXACIN HYDROCHLORIDE AND SODIUM CHLORIDE INJECTION Regulatory Filings	2021-07-09	English
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE Transaction in Own Shares	2021-07-08	English
Next Day Disclosure Return Transaction in Own Shares	2021-07-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2021 Share Issue/Capital Change	2021-07-06	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 30 JUNE 2021 AND DIVIDEND PAYMENT Declaration of Voting Results & Voting Rights Announcements	2021-06-30	English
Next Day Disclosure Return Transaction in Own Shares	2021-06-24	English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2020 Environmental & Social Information	2021-06-21	English
CLARIFICATION ANNOUNCEMENT Regulatory Filings	2021-06-18	English
VOLUNTARY ANNOUNCEMENT-SIHUAN PHARMACEUTICAL OBTAINED DRUG REGISTRATION APPROVAL IN RELATION TO CASPOFUNGIN ACETATE FOR INJECTION Regulatory Filings	2021-06-16	English
VOLUNTARY ANNOUNCEMENT - Diabetes Innovation Drug Insulin Degludec and Insulin Aspart Injection Obtained Approval for First Clinical Trial of Biosimilar in China Regulatory Filings	2021-06-07	English
VOLUNTARY ANNOUNCEMENT-SIHUAN PHARMACEUTICAL ENTERS INTO STRATEGIC COOPERATION WITH AMERICAN COMPANY GENESIS BIOSYSTEMS ON LIPIVAGE FAT COLLECTION SYSTEM Capital/Financing Update	2021-06-04	English
VOLUNTARY ANNOUNCEMENT-XUANZHU BIOPHARM HAS ACQUIRED CLINICAL TRIAL APPROVAL FOR THE NEW DRUG XZP-5955 TABLET Regulatory Filings	2021-06-03	English
VOLUNTARY ANNOUNCEMENT SIHUAN PHARMACEUTICAL BECOMES THE SOLE AGENT IN CHINA OF ELASTY FACIAL EMBEDDING THREAD (THREAD LIFTING) AND PRIVATE-USE THREAD PRODUCTS OF DONGBANG MEDICAL KOREA Regulatory Filings	2021-06-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2021 Share Issue/Capital Change	2021-06-01	English
Notification Letter and Request Form to Non-registered Holder Report Publication Announcement	2021-05-28	English
Notification Letter and Change Request Form to Registered Holder Report Publication Announcement	2021-05-28	English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2021-05-28	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2021-05-28	English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, DECLARATION AND PAYMENT OF A FINAL CASH DIVIDEND, RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2021-05-28	English
VOLUNTARY ANNOUNCEMENT-SIHUAN PHARMACEUTICAL IS GRANTED THE EXCLUSIVE MARKETING RIGHTS FOR METOPROLOL SUCCINATE SUSTAINED-RELEASE TABLETS IN CHINA Regulatory Filings	2021-05-28	English
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE Transaction in Own Shares	2021-05-07	English
Next Day Disclosure Return Share Issue/Capital Change	2021-05-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2021 Capital/Financing Update	2021-05-04	English
VOLUNTARY ANNOUNCEMENT-ENTERING INTO STRATEGIC COOPERATION AGREEMENT BETWEEN JILIN HUISHENG BIOPHARMACEUTICAL AND PORTON PHARMA Regulatory Filings	2021-04-28	English
Next Day Disclosure Returns Transaction in Own Shares	2021-04-09	English
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE Transaction in Own Shares	2021-04-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2021 Share Issue/Capital Change	2021-04-08	English
VOLUNTARY ANNOUNCEMENT-SIHUAN PHARMACEUTICAL OBTAINED DRUG REGISTRATION APPROVAL IN RELATION TO AMBROXOL HYDROCHLORIDE INJECTION Regulatory Filings	2021-04-01	English
Notification Letter and Request Form to Non-registered Holder Report Publication Announcement	2021-03-30	English
Notification Letter and Change Request Form to Registered Holder Report Publication Announcement	2021-03-30	English
Annual Report 2020 Annual Report FY 2020	2021-03-30	English
VOLUNTARY ANNOUNCEMENT PROPOSED SHARE REPURCHASE UNDER THE GENERAL MANDATE Transaction in Own Shares	2021-03-28	English
VOLUNTARY ANNOUNCEMENT SIHUAN PHARMACEUTICAL OBTAINED DRUG REGISTRATION APPROVAL IN RELATION TO RIVAROXABAN TABLETS Regulatory Filings	2021-03-25	English
ANNOUCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2020 Annual Report FY 2020	2021-03-23	English
NOTICE OF BOARD MEETING Regulatory Filings	2021-03-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2021 Share Issue/Capital Change	2021-03-01	English
VOLUNTARY ANNOUNCEMENT THE GROUP'S LIRAGLUTIDE HAS COMPLETED PHASE I CLINICAL STUDY FOR INDICATION OF WEIGHT LOSS Regulatory Filings	2021-02-26	English
VOLUNTARY ANNOUNCEMENT-APPROVAL TO LAUNCH THE GROUP'S EXCLUSIVE KOREAN BOTULINUM TOXIN PRODUCT "LETYBO 50U" IN THE PRC MARKET Regulatory Filings	2021-02-10	English
VOLUNTARY ANNOUNCEMENT - THE GROUP IS THE FIRST ENTERPRISE WITH ITS OCTREOTIDE ACETATE INJECTION PASSING THE CONSISTENCY EVALUATION Regulatory Filings	2021-02-08	English
VOLUNTARY ANNOUNCEMENT - PANTOPRAZOLE SODIUM INJECTION AND IBUPROFEN INJECTION OF THE GROUP ARE INCLUDED IN THE FOURTH BATCH OF NATIONAL DRUG CENTRALIZED PROCUREMENT LIST Regulatory Filings	2021-02-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2021 Share Issue/Capital Change	2021-02-02	English
VOLUNTARY ANNOUNCEMENT - XUANZHU BIOPHARM'S MEDICAL PRODUCTS FOR THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS OBTAINED APPROVAL FOR CLINICAL TRIALS Regulatory Filings	2021-01-29	English
VOLUNTARY ANNOUNCEMENT - STRATEGIC INVESTMENT IN SHENZHEN MILEBOT ROBOTICS CO., LTD. Capital/Financing Update	2021-01-29	English
VOLUNTARY ANNOUNCEMENT-CINEPAZIDE MALEATE INJECTION (KELINAO) OF SIHUAN PHARMACEUTICAL OBTAINED APPROVAL FOR NEW INDICATION Capital/Financing Update	2021-01-27	English
VOLUNTARY ANNOUNCEMENT ACQUISITION OF JILIN AOTONG CHEMICAL CO., LTD. AND JILIN JIAHUI CHEMICAL CO., LTD. M&A Activity	2021-01-27	English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR PANTOPRAZOLE SODIUM INJECTION OF SIHUAN PHARMACEUTICAL Regulatory Filings	2021-01-26	English
VOLUNTARY ANNOUNCEMENT - ACQUISITION OF BEIJING COMBIO PHARMACEUTICAL INC. M&A Activity	2021-01-26	English
CONNECTED TRANSACTION SUBSCRIPTION OF SHARES IN A SUBSIDIARY OF THE COMPANY Capital/Financing Update	2021-01-21	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2020 Share Issue/Capital Change	2021-01-04	English

Filings by year

2026 33 filings
2025 93 filings
2024 55 filings
2023 68 filings
2022 73 filings
2021 126 filings
2020 53 filings
2019 45 filings
2018 39 filings
2017 60 filings
2016 88 filings
2015 49 filings
2014 44 filings
2013 41 filings
2012 38 filings
2011 46 filings
2010 11 filings